M. Bilici et al., Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments, J AFFECT D, 64(1), 2001, pp. 43-51
Background: Reactive oxygen species (ROS) may play a role in some neuropsyc
hiatric disorders. There is some evidence that the activation of immune-inf
lammatory process, increase of monoamines catabolism, and abnormalities in
lipid compounds may cause overproduction of ROS and, in turn, antioxidative
enzyme activities (AEAs) and lipid peroxidation (LP), and that these pheno
mena may be related to pathophysiology of major depression. Methods: The ai
ms of this study were (i) to examine the AEAs and LP levels of the major de
pressed (MD) patients, and to compare these with healthy controls; and (ii)
to investigate the effect of subchronic treatment with selective serotonin
reuptake inhibitors (SSRIs) on AEAs and LP levels in MD subjects, Thirty M
D patients, and 32 healthy controls (HC) participated in this study. AEAs a
nd LP levels were determined by measuring several antioxidative enzymes and
malondialdehyde (MDA levels in plasma and/or in red blood cells. Results:
Major depressed patients, especially melancholic patients, had higher AEA a
nd LP levels than those of healthy controls. After treatment for 3 months w
ith SSRIs, AEA and LP levels of the patients were significantly decreased t
o normal levels. Conclusion: These findings suggest that (i) major depressi
on, especially with melancholia, is associated with elevated AEAs and LP, a
nd that (ii) subchronic treatment with SSRIs may have a suppressive effect
on AEA and LP. Clinical implication and limitation: AEAs might be used for
monitoring SSRIs effects. (C) 2001 Elsevier Science B.V. All rights reserve
d.